Propanc Biopharma (PPCB) 10-Q2014 Q1 Quarterly report

Filed: 14 Nov 13, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: advanced, BSM, Carlo, closing, customary, demined, designated, determined, discount, Entity, equal, expire, face, fee, formal, forward, free, hedge, hedging, initial, initially, lender, method, model, Monte, option, payroll, prime, professional, purpose, reclassified, remaining, repricing, reset, retainer, revalued, roll, space, table, thinly, Topic, traded, treasury, unrelated, utilizing, variable, volatility, warrant

Removed: accruing, amortization, attributable, authorized, bearing, clause, contract, converted, decrease, escalation, February, issue, lease, monthly, notice, offering, portion, prepaid, primarily, principle, prior, protection, ratchet, ratcheted, rendered, renegotiated, rent, repayable, Russia, stockholder, voluntary

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

PPCB similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

CERTIFICATION OF

CHIEF EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350

In connection with the accompanying Quarterly Report on Form 10-Q of Propanc Health Group Corporation (the “Company”), for the quarter ending September 30, 2013, I, James Nathanielsz, Chief Executive Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge, that:

1. Such Quarterly Report on Form 10-Q for the quarter ending September 30, 2013, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in such Quarterly Report on Form 10-Q for the quarter ending September 30, 2013, fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 14, 2013	By:	/s/ James Nathanielsz
		Name: James Nathanielsz
		Title: Chief Executive Officer